Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire RUCHI G.

India

Highly motivated Oncology expert with over 4.5 years of experience in managing and performing pre-clinical research.

Profile Summary

Articulate communicator and persuasive relationship builder with the ability to interpret and communicate complex scientific information to the scientific medical community. An active team player, adapting well to fast-paced environments with proven ability in handling multiple projects. Good working knowledge of drug-development process, medical terminology, oncology advancement techniques and biological sample regulations.

Subject Matter Expertise

• ★ Oncology
• ☆ RNA Sequencing
• ☆ Drug Development
• ☆ Metabolism & Metabolic Disease

Services

• Writing
• Research
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing

Research Market Research, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Data & AI Statistical Analysis

Product Development Formulation

Work Experience

Postdoctoral Research Associate

Washington University in St Louis

September 2018 - October 2020

Postdoctoral Fellow

Moffitt Cancer Center

November 2017 - August 2018

Postdoctoral Fellow

Henry Ford Health System

March 2016 - November 2017

Education

Ph.D (Cellular and Molecular Neuroscience)

National Brain Research Centre

August 2009 - August 2015

MSc. (Cellular and Molecular Neuroscience)

National Brain Research Centre

2009 - 2010

BSc. (Biosciences)

Sri Venkateswara College, Delhi University

2006 - 2009

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Ghildiyal, R., Sen, E.(2017). Concerted action of histone methyltransferases G9a and PRMT-1 regulates PGC-1α-RIG-I axis in IFNγ treated glioma cells . Cytokine. 89. p. 185-193.

Ghildiyal, R., Sen, E.(2017). CK2 induced RIG-I drives metabolic adaptations in IFNγ-treated glioma cells . Cytokine. 89. p. 219-228.

(2016). CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma . Experimental cell research.

Dixit, D., Ahmad, F., Ghildiyal, R., Joshi, S.D., Sen, E.(2016). CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma . Experimental Cell Research. 344. (1). p. 132-142.

(2015). Concerted action of histone methyltransferases G9a and PRMT-1 regulates PGC-1α-RIG-I axis in IFNγ treated glioma cells . Cytokine.

(2015). CK2 induced RIG-I drives metabolic adaptations in IFNγ-treated glioma cells . Cytokine.

(2014). Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism . Cell death & disease.

Dixit, D., Ghildiyal, R., Anto, N.P., Sen, E.(2014). Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism . Cell Death and Disease. 5. (5).

(2013). ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα . Cell death & disease.

(2013). Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner . Cancer letters.

Dixit, D., Ghildiyal, R., Anto, N.P., Ghosh, S., Sharma, V., Sen, E.(2013). Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner . Cancer Letters. 336. (2). p. 347-358.

Sinha, S., Ghildiyal, R., Mehta, V.S., Sen, E.(2013). ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα . Cell Death and Disease. 4. (5).

Ghildiyal, R., Dixit, D., Sen, E.(2013). EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells . Molecular Carcinogenesis. 52. (12). p. 970-982.

(2012). EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells . Molecular carcinogenesis.